Categories
Pharmaceutical

Intraoperative sensor Market Unidentified Segments – The Biggest Opportunity Of 2021

The global intraoperative sensors market is expected to grow at a positive pace as intraoperative sensors have become a key technology used in the treatment of orthopedic medical procedures. According to a study by Fact MR, increasing focus on making intraoperative sensors smarter will aid the overall expansion of the market. The rising incidence of orthopedic disorders, kidney related disorder, and optic related ailments, will result in higher demand for intraoperative sensors.

Key manufacturers are investigating in research initiatives to expand their portfolio. The participants in the market are continuously converging in on launching mechanically progressed intraoperative sensors. Some of the manufacturers are focusing on launching novel technologies such as 3D/4D imaging and others to aid minimally invasive surgical procedures.

Due to the rising interest in the advance healthcare and presence of some of the leading market players, North America has emerged as the leading market for intraoperative sensors. According to the American Hospital Association, about 2/3rd of healthcare providers in the U.S. are adopting novel technologies. This presents a conducive environment for sales of intraoperative sensors.

Request For A Brochure : https://www.factmr.com/connectus/sample?flag=T&rep_id=5642

Competitive Landscape

Some of the leading manufacturers in the intraoperative sensors market are Posifa Technologies Measurement Specialties Inc., Koninklijke Philips N.V., ABB Group, Honeywell International Inc., Analog Devices, Robert Bosch GmbH Smiths Medical STMicroelectronics NV, STMicroelectronics, Medtronic PLC,m First Sensor AG, GE Healthcare, Siemens AG and Samsung Electronics Co. Ltd.

Fact.MR has identified the market as overly fragmented in nature. Prominent players are joining hands with top healthcare and biopharma companies to maintain their lead in the market. Besides this, product launches have remained a key strategy. For example, in March 2018, Philips received clearance for the launch of Big Bore sliding gantry, which reviews, diagnoses, and analyzes images faster than technologies with low dose exposure.

More Insights on the Intraoperative sensors market

In its latest report, Fact.MR offers unbiased analysis of the intraoperative sensor market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (Temperature sensor, Pressure sensor, Soft tissue sensor, and Robotic Operative sensor), Modality (Physical occlusion heat, Ferrous objects, Magnetic fields temp, Ambient light, and Metal reflectors occlusion) end user (Hospitals, Ambulatory Surgical Centers, Specialized Orthopaedic Centers), across seven regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa).

Key Segments of Intraoperative sensor Market Covered in the Report

Based on the product Type, the Intraoperative sensor market has been segmented as

  • Temperature sensor
  • Pressure sensor
  • Soft tissue sensor
  • Robotic Operative sensor

Explore tables and figures of the study. Request ToC of the report at

https://www.factmr.com/connectus/sample?flag=T&rep_id=5642

Based on the Modality, the Intraoperative sensor market has been segmented as

  • Physical occlusion heat
  • Ferrous objects
  • Magnetic fields temp.
  • Ambient light
  • Metal reflectors occlusion

Based on application, the Intraoperative sensor market has been segmented as

  • Orthopedic surgery
  • Optic Surgery
  • Soft Tissues Surgery
  • Kidney dialysis machines
  • Infusion and insulin pumps
  • Blood analyzers, respiratory monitoring
  • Blood pressure monitoring equipment
  • Endochondral ossification
  • Other Indications

Based on end-users, the Intraoperative sensor market has been segmented as

  • Hospitals
  • Ambulatory Surgical
  • Specialty Clinics
  • Research institutes

Key Takeaways

  • Willingness to spend on advanced healthcare will support growth in the U.S.
  • Favorable government and healthcare policies in Canada will present attractive opportunities for growth.
  • Increasing spending on expansion of healthcare infrastructure will catapult India as a key market for intraoperative sensors.
  • Rising demand for advanced healthcare will push growth in China and Japan.
  • Hospitals will remain key end users on account of registering higher footfall of patients.

Explore Fact.MR’s Coverage on the Biospace Domain

Interventional ENT Devices Market: Fact.MR has published a study to elucidate the potential growth parameters of the Interventional ENT Devices market.

Diagnostic Imaging Services Market: The global diagnostic imaging services market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook.

Portable Dialysis Machines Market: Fact. MR’s extensive coverage on portable dialysis machines market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com

Categories
Pharmaceutical

Mobile Continuous Patient Monitors Market: North America is anticipated to be the dominant market reveals Fact.MR’s study

Fact.MR’s report on the global mobile continuous patient monitor market forecasts a steady growth through 2021 owing to the burgeoning demand for technologically equipped devices to track patients’ health at home. Following the outbreak of COVID-19, the rising investments in the development of compact and portable devices and rising cases of chronic diseases have fuelled the demand for mobile continuous patient monitors.

According to the study, the focus on reducing clinical visits, which often acts as a challenge for patients with mobility issues will continue driving growth in 2021. Considering this, some of the leading companies have been investing in launch of cutting-edge technologies, which will bode well for the market. 

Request For A Brochure: https://www.factmr.com/connectus/sample?flag=S&rep_id=3348  

In January 2021, Biobeat, a global leader in continuous remote patient monitoring solutions for continuous health monitoring launched a health AI hospital at home monitoring kit. It provided medical staff with brief view of patient’s health and predictive AI patient deterioration system.

Key Takeaways

  • United States is projected to emerge as the largest market for mobile continuous patient monitor
  • The UK and France are expected to emerge as lucrative markets within Europe
  • China is expected to account for the highest revenue share in East Asia through 2021 and beyond
  • India is expected to emerge as a potential market backed by the technological advancement in monitoring devices
  • Based on indication, ECG and blood pressure are projected to dominate the market owing to the rising prevalence of diabetes and heart disease
  • Portable and compact mobile continuous patient monitor devices are forecast to gain from the rising demand from consumers

Prominent Drivers

  • Technological advancements in the patient monitoring device and the updated technological sensors to boost the demand
  • Rising prevalence of the chronic disease and patients inclination to wear mobile patient monitor to bolster the growth
  • Soaring demand for wireless monitoring devices among manufacturers is accelerating the mobile continuous patient monitor sales
  • Demand for home care kit and remote medical services during pandemic to increase patient monitor device sales through 2031

Key Restraints

  • Information leak and invasive properties associated with the monitoring devices is likely to hinder the growth
  • High cost of the devices and inadequate reimbursement policies to limit the demand of market

Share Your Requirements & Get Customized Reports: https://www.factmr.com/connectus/sample?flag=T&rep_id=3348

Competitive Landscape

Some of the prominent players identified in global mobile continuous patient monitor by Fact.MR includes OSI systems Inc., Schiller, Huntleigh Healthcare Limited, HEYER Medical AG, ELCAT, Promed Group Co., Radiometer Medical ApS, Masimo., myErka, Kalamed Medical Systems, Nihon Kohden Corporation, Koninklijke Philips, CNSystems Medizintechnik GmbH., Ltd., and Trimpeks among others. Key manufacturers are adopting R&D activities and mergers as an important strategy for their future expansion projects.

In February 2021, researchers at University of California San Diego launched a mHealth wearable monitor device that uses a patch to monitor cardiovascular signs and multiple biomarkers simultaneously.

Likewise, in August 2020, Statis lab launched app-connected remote patient monitoring platform in United States that tracks six vital signs with traditional vital sensors and is supporting cloud platform.

More Insights on the Mobile Continuous Patient Monitor Market

Fact.MR sheds an in-depth analysis on global mobile continuous patient monitor market. The report offers a detailed segmentation on mobile continuous patient monitor market on the basis of product type (portable & compact and floor standing), indications (ECG, blood pressure, temperature, and hemoglobin), end-users (intensive care, ambulatory surgical center, hospitals and home care settings), and regions (North America, Latin America, Eastern Europe, Western Europe, Japan, Asia Pacific excluding Japan and China, China and Middle East & Africa)

Fact.MR’s Trending Reports – http://www.globenewswire.com/en/news-release/2020/03/27/2007702/0/en/Tricuspid-Valve-Repair-Market-Poised-for-Astounding-Growth-Through-2029-Fact-MR-Projects-Annuloplasty-Rings-to-Remain-Top-Selling.html

Explore Fact.MR’s Coverage on the Healthcare Domain

Patient temperature management systems Market: A recent study by Fact.MR on the patient temperature management systems market offers an unbiased analysis on the opportunities and trends through 2021 and beyond. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the challenges, restraints, and opportunities for key market players along with key stakeholders and emerging players.

Next-generation patient monitoring devices Market: A detailed assessment of next-generation patient monitoring devices’ market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the market along with their product portfolios enhances the reliability of this comprehensive research study.

Patient temperature management systems Market: Fact.MR delivers a detailed analysis on global patient temperature management systems market with the strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you a detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com

Categories
Pharmaceutical

Antibiotic-loaded Bone Cement Market (COVID-19) to Witness Astonishing Growth by Forecast 2021-2031

Antibiotic-loaded Bone Cement market is anticipated to gain a steady growth pace in 2021 & beyond. Growth of these systems could be mainly due to growing awareness in relation to the therapeutic advantages of application of antibiotic-loaded bone cement in orthopaedic surgeries, growing number of elderly population, and increasing adoption of antibiotic-loaded bone cement in most of the ortho-surgeries, for instance, knee joint and hip infections. 

Growing Awareness and Increasing R&D Activities to Propel the Industry Growth

The increasing knowledge in relation to the therapeutic usage of antibiotic bone cement in the treatment of knee joint and hip infections is considerably contributing to the market growth. To prevent bone infections, various strategies have been implemented in the past few years, which incorporate strict and effective systemic antibiotic prophylaxis and antiseptic operative procedures.

Amid these procedures, the usage of antibiotic loaded bone cement is gaining traction. The increasing prevalence of hip and knee replacement surgeries and osteoporosis, mainly amid the rising elderly population, is further fueling the demand for the product.

Request For A Brochure : https://www.factmr.com/connectus/sample?flag=S&rep_id=867

Vancomycin Loaded Antibody Type is Poised to Gain Highest Market Share

Gentamicin and vancomycin loaded antibody, both types are anticipated to remain prevalent in the global market as a result of ease of availability in the ready‐mixed form. However, a limitation has been recorded in several studies is that the antibiotic powder utilized in manual mixing of these antibodies is a commercial gentamicin sulfate, which is a blend of different substances, this can lead to loss of market share in the forthcoming years.

On the other hand, the mix (vancomycin and ciprofloxacin) is anticipated to gain traction as it shows a stronger release than hydrochloride ciprofloxacin alone.

How Big is the US Antibiotic-loaded Bone Cement Market?

The US is anticipated to remain lucrative as a result of the cutting-edge bone grafting procedures in the region as well as favorable reimbursement landscape. The UK reflects the second most lucrative region, while France, Italy, U.K. and Germany are also anticipated to witness sound growth prospects in 2021 & beyond.

On the other hand, China, India and Japan reflects the maximum growth pace in 2021 & beyond as a result of the growing access to healthcare facilities and enhancing healthcare infrastructure.

Product Advancements & Launches, Mergers & Acquisitions Remain Key Focus Area: Fact.MR Survey

Antibiotic-loaded Bone Cement market has presence of leading market players. Fact.MR’s survey with thought leaders revealed that market players are investing profoundly in offering more efficient products to cope with several problems occurred amid orthopedic surgeries as well as merger & acquistions in 2021 & beyond. The updated edition of the report provides comprehensive coverage of the projected to remain the key strategies of market players. Some of the players profiled in the report are antibiotic-loaded bone cement market includes Zimmer Biomet, Stryker Corporation,Tecres s.p.a., Teknimed, DePuy Synthes, Heraeus Holding, Exactech, Inc., and others. The updated edition also offers a detailed analysis of the COVID-19 impact on this market.

To receive extensive list of important regions, ask for TOC here@ https://www.factmr.com/connectus/sample?flag=T&rep_id=867

Antibiotic-loaded Bone Cement market: Segmentation

By Loaded Antibody Type:

  • Tobramycin
  • Gentamicin
  • Vancomycin
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies
  • Drug Stores

For reducing bone infections, several strategies have been adopted in the last few years such as stringent and efficient antiseptic operative procedures and systemic antibiotic prophylaxis. The rate of infections has observed a significant reduction from 5–10% to approximately 1-2% during the last twenty years. Among these procedures, the use of antibiotic enriched bone cement is widely used. There exist several issues which are still controversial regarding the use of antibiotic-loaded bone cement such as bacterial adhesion, antibiotic resistance as well as modification in the mechanical properties of the bone cement.

Antibiotic-loaded Bone Cement market: Key Players

Some of the players in the Antibiotic-loaded Bone Cement market includes Stryker Corporation, Zimmer Biomet, Tecres s.p.a., DePuy Synthes, Teknimed, Exactech, Inc., Heraeus Holding and others.

Fact.MR’s Trending Reports – http://www.globenewswire.com/en/news-release/2020/03/27/2007702/0/en/Tricuspid-Valve-Repair-Market-Poised-for-Astounding-Growth-Through-2029-Fact-MR-Projects-Annuloplasty-Rings-to-Remain-Top-Selling.html

Explore Fact.MR’s Healthcare Reports 

Flow Cytometry Market : Delve into Fact.MR’s extensive study on the flow cytometry market, offering detailed assessment. The study analyses crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities.

Robotic Hair Transplant System Market: The global robotic hair transplant system market study published by Fact.MR incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets.

Oncology Biosimilars Market: Fact.MR’s global oncology biosimilarsmarket research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com

Categories
Pharmaceutical

Global Bronchial Blocker Devices Market Is Segmented By Product Type, End Users and Geography

Healthcare modernization, both in terms of infrastructure and services, has propelled the industry to new heights. Emerging economies have upgraded their healthcare systems as a result of economic development and increased patient awareness. Companies in the healthcare industry have also risen to new heights thanks to government assistance and favourable healthcare reforms.

Fact.MR has used a versatile approach to focus attention on the historical evolution, Sales and Demand of Bronchial blocker Devices Market. Drivers and constraints, threats and opportunities, regional segmentation and opportunity assessment, end-use/application prospects review, and competitive landscape assessment are just a few of the topics addressed in the Global Bronchial blocker Devices Market report. 

Request For A Brochure: https://www.factmr.com/connectus/sample?flag=B&rep_id=863

The global market for Bronchial blocker devices is segmented on basis of product type, end users, and geography:

Segment by Product Type

  • Fogarty vascular embolectomy catheter
  • Single-lumen endotracheal tube
  • Wire-guided endobronchial blocker

Segment by End Users

  • Hospitals
  • Ambulatory Surgical Centres

The global bronchial blocker devices market is segmented by product type, end users and geography. Based on the product type, the global bronchial blocker devices market is segmented into Univent System, Arndt Endobronchial Blockers, Cohen Flexitip Endobronchial Blockers, Folly Catheters and EZ-Blocker. Fogarty catheter is expected to dominate the bronchial blocker devices market due to ease in use in pediatric patients and is popular due to its comparative low cost.

On the basis of regional presence, global bronchial blocker devices market is segmented into five key regions viz.  North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America leads the bronchial blocker devices market reasons being presence of leading players, favorable reimbursement policies and increased number of thoracic surgeries. Manufacturers are targeting developed markets due to rise in thoracic surgeries in this developing countries.

Bronchial blocker Devices Market: Key Players

Europe is the second leading market for bronchial blocker devices market due increased healthcare spending per person, and government support. The Asia Pacific market is also expected to grow at a higher rate owing to large patient pool, and product awareness due to medical conferences. These factors are likely to drive the market growth of bronchial blocker devices market during the forecast period globally.

Some of the major players in bronchial blocker devices market are Fuji Systems Corporation, Teleflex Inc., Cook Medical, Edwards Lifesciences, ETView Medical Ltd., Daiken Medical Co Ltd, and others

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=863

The report covers exhaustive analysis on:

  • Bronchial Blocker Devices Market Segments
  • Bronchial Blocker Devices Market Dynamics
  • Historical Actual Market Size, 2013- 2017
  • Bronchial Blocker Devices Market Size & Forecast, 2018 to 2026
  • Bronchial Blocker Devices Market Current Trends/Issues/Challenges
  • Competition & Companies Involved
  • Bronchial Blocker Devices Market Drivers And Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Read More Trending Reports of Fact.MR : https://www.biospace.com/article/platelet-rich-plasma-market-players-eye-opportunities-arising-in-sports-injury-management/

Explore Fact.MR’s Healthcare Reports

Hospital Asset Management Market: Delve into Fact.MR’s extensive study on the hospital asset management market, offering detailed assessment. The study analyses crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities.

Aneurysm Clips Market: The global aneurysm clips market study published by Fact.MR incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets.

Aptamers Market: Fact.MR’s global aptamers market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com

Categories
Pharmaceutical

Sales of Stent Graft Balloon Catheter In Cardiac Catheterization Laboratories Is Surged with a CAGR of 5.1% By 2022

The global demand for stent graft balloon catheter will register a healthy expansion during 2017 to 2022. Revenues from the market are expected to surpass US$ 1,000 Mn by the end of 2022.

Usually utilized in bypass graft surgery as well as balloon angioplasty, stent graft balloon catheters prevent risks concerning occurrence of re-narrowing in patients undergoing angioplasty, and risks related to abrupt artery closure. Owing to these advantages offered by stent graft balloon catheters, their demand is witnessing a rise. A gradual evolution has been observed in the stent graft balloon catheter market, from the simple stents to modification of balloon stent catheters. Since recent past, there has been a surge in hospital admissions caused by increasing cases of atherosclerosis, and soaring prevalence of CAD – coronary artery disease globally.

Numerous developments have been realized in technology of balloon catheters, along with the hike in healthcare expenditure. These factors are expected to augment growth of the market. In contrast, high prices of angioplasty procedures has become a problem for population across developing and underdeveloped economies. This might act as an impeding factor for the market growth.

To remain ‘ahead’ of your competitors, request a sample

https://www.factmr.com/connectus/sample?flag=S&rep_id=149

Growth of the global stent graft balloon catheter market has been highly favored by the advent of drug eluting balloons. In addition, shifting preferences towards using balloons with drug delivery, and helping to deliver medications at local sites, has deemed them to be effective substitutes for administering drugs intravenously. Various new products developed are being approved for treatment of vascular diseases. For instance – recently, the FDA has approved use of expandable balloon stent graft introduced by the W.L. Gore & Associates to treat peripheral artery disease. Moreover, technology advancements in the stent graft balloon catheters, coupled with increasing awareness about angioplasty, and sophisticated healthcare infrastructure in developed economies are further poised to drive the market growth in the near future.

For critical insights on this market, request for methodology here-

https://www.factmr.com/connectus/sample?flag=RM&rep_id=149

Market Taxonomy

Indication
  • Coronary Artery Disease
  • Peripheral Vascular Disease
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories
Raw Material
  • Polyurethane
  • Nylon
  • Others

Speak To Research Analyst For Detailed Insights:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=149

9 Key Estimations from Fact.MR’s Report on the Global Stent Graft Balloon Catheter Market

  1. Based on raw material, sales of polyurethane for producing stent graft balloon catheters will register a steady expansion, while sales of nylon are estimated to register a sluggish growth through 2022.
  2. Cardiac catheterization laboratories are anticipated to become the fastest growing end-users in the global stent graft balloon catheter market.
  3. Ambulatory surgical centres are expected to be the least lucrative end-users of stent graft balloon catheters.
  4. Hospitals will continue to be the largest end-user segment, with sales poised to reach nearly US$ 900 Mn by 2022-end.
  5. Sales of stent graft balloon catheters for coronary artery disease indication are projected to account for over two-third share of the market over the forecast period, in terms of revenues.
  6. Demand for stent graft balloon catheters from peripheral vascular disease indication segment will remain sluggish in the market.
  7. Although, the market in Middle East & Africa (MEA) is expected to register a sluggish expansion, sales of stent graft balloon catheter in this region are estimated to gain an uptick by 2022-end.
  8. Europe will continue to be the largest market for stent graft balloon catheter, with sales projected to exceed US$ 400 Mn in revenues by 2022-end.Key players contributing to the growth of the market

    Meril Life Sciences Pvt. Ltd. Abbott Laboratories, Hexacath, Cardionovum GmbH, Jotech GmbH, MicroPort Scientific Corporation, Boston Scientific Corporation, Terumo Corporation, Cook Medical INC, B. Braun Melsungen AG, Cordis Corporation, and Medtronic Plc.

For More Insights

https://www.biospace.com/article/unhealthy-lifestyle-habits-and-improving-awareness-about-new-therapeutics-are-two-key-factors-driving-osteopenia-treatment-market-growth-notes-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

What are the Factors Spearheading the Growth of Citicoline In US : Check Latest Report

The Fact.MR report tracks the citicoline market for the period 2018-2028. According to the report, the Demand for citicoline is projected to grow at 8.5% CAGR through 2028.

The Growth of Citicoline Market is huge. The Market study analyzes each market player encompassed in the market study as per its market share, production footprint, current launches, agreements, ongoing R&D projects, and market strategies. SWOT analysis has been performed in the market study to investigate the strengths, weaknesses, opportunities and threats of each player.

According to a recent research by Fact.MR, the citicoline market is estimated to surpass US$ 550 million in 2019. Citicoline demand is driven by a range of factors, notably increasing geriatric population and growing use among eSports players. The study offers in-depth and incisive insights on key factors influencing the global demand for citicoline.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=2868

Supplement Consumption Among eSports Players: A Lucrative Opportunity

Growing popularity and increasing investments in electronic Sports is helping the market go mainstream which, in turn, is opening an assortment of opportunities for various industries. Players participating in eSports tournaments are seeking cognitive enhancing supplements which can help them concentrate, plot strategies, and improve working memory.

Additionally, a ban on the use of other nootropics such as Ritalin and Adderall in eSports leagues is creating demand for ‘permissible’ supplements. Citicoline’s negligible toxicity and its organic nature is making it an appealing prospect for eSports players. With regulations allowing the use of citicoline in functional food and supplements, manufacturers are increasingly focusing towards including the compound in their products to capitalize on the bolstering demand for cognitive-enhancing supplements in eSports.

For critical insights on this market, request for methodology here –  https://www.factmr.com/connectus/sample?flag=RM&rep_id=2868

citicoline market taxonomy

Citicoline’s Role in Ischemic Stroke Treatment Creating Opportunities

The adverse and often fatal impact of ischemic stroke on human health, coupled with increasing prevalence is bolstering demand for effective treatment of the condition. According to WHO, stroke is the second leading cause of death in the world and the third leading cause of disabilities in adults.

Additionally, the lack of a standard procedure of treatment for different ischemic stroke patients is influencing healthcare researchers to focus on the development of acute therapy for all patients. According to Fact.MR’s study, citicoline is being viewed as a potential treatment option by researchers and healthcare providers. These factors are vital to citicoline market growth and are expected propel proliferation during the forecast period.

The study opines that citicoline demand is also likely to be influenced by its role in treatment of brain injuries. Studies suggest treatment of patients with citicoline has been beneficial in reducing headaches, dizziness, tinnitus, and in substantially relieving motor, cognitive, and mental symptoms.

Read More Trending Reports of Fact.MR-

https://www.prnewswire.com/news-releases/respiratory-virus-vaccines-rd-focused-on-covid-19-efforts-factmr-301230897.html

These developments are further driving researchers towards testing its potential use in treatment for pervasive developmental disorders such as atypical autism, Asperger Syndrome, and autism. Intensifying clinical trials and research and developmental activities in the area are expected to open new and lucrative opportunities for companies in the citicoline market.

Increasing Demand for Memory-boosting Supplements for Elderly to Bolster Market Growth

The growth in the geriatric population around the world is expected to continue with the Population Reference Bureau (PRB) estimating the number of people aged over 65 to account for 16 percent of the world population by 2050. Citicoline finds widespread usage in the production of supplements for enhancing cognition in the elderly.

In addition, intensifying clinical trials towards improving citicoline efficacy through its synergy with other chemicals is another vital factor estimated to drive market growth. Fact.MR opines that advancements in tablet manufacturing will bolster production of highly effective supplements, with sales of citicoline tablets estimated to reach nearly US$ 235 million in 2019.

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/2868

citicoline market snapshot

Key findings of the report:

  • Prominent manufacturers, raw material suppliers, equipment providers, traders, and distributors in the market.
  • In-depth analysis of important market segments, market potential, impacting trends, and challenges.
  • Critical examination of the strengths, weaknesses, opportunities and threats of each player.
  • Extensive investigation of the effects of the growth of relevant industries.
  • Accurate data regarding the future prospects of the during the forecast period.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Sales of eCOA, eSource, & Clinical Trials are Envisaged to Register a CAGR of ~14% through 2029

Fact.MR study provides the long-term outlook of the eCOA, eSource, & clinical trials market for 2019 to 2029. The sales of eCOA, eSource, & clinical trials are envisaged to register a CAGR of ~14% through 2029.

The latest Fact.MR study indicates healthcare facilities, contract research organizations, and educational & research institutes collectively spent ~US$ 1,950 Mn on eCOA, eSource and clinical trials solutions in 2018. The demand for eCOA,eSource & clinical trials is envisaged to witness substantial traction through 2019, with gains primarily driven by the growing penetration of digitization in healthcare sector and substantial increase in pharma spending on clinical trials.

Click HERE To get a SAMPLE (Including Full TOC, Table & Figures) at https://www.factmr.com/connectus/sample?flag=S&rep_id=4042

Rapidly expanding deployment of clinical trial solutions, which contributed to ~40% of the total spending on eCOA, eSource, and clinical trials in 2018, will continue to appeal a widening bandwidth of institutions through 2029, says the report.

clinical trials industry structure

Market Segmentation

Global ECOA, eSource & Clinical Trials Spending 2014-2018 and Forecast 2019-2029, by Solution Type 

eCOA  (Electronic clinical Outcome assessment)
ePROs (Patient Reported Outcomes)
ClinROs (Clinician Reported Outcomes)
ObsROs (Observer reported Outcomes)
PerfOs (Performance Outcomes)
eSource
Clinical Trials Solutions
Clinical Data Management Systems (CDMS)
Clinical Trial Management Systems (CTMS)
Randomization and Trial Supply Management Systems (RTMS)
Trail Planning and Safety Solutions
Electronic Data Capture (EDC)

Global ECOA, eSource & Clinical Trials Spending Analysis 2014-2018 and Forecast 2019-2029, by Deployment

  • Licensed Enterprise (On Premise)
  • Cloud-based (SaaS)

Global ECOA, eSource & Clinical Trials Spending Analysis 2014-2018 and Forecast 2019-2029, by End User

Contract Research Organizations
Hospitals & Other Healthcare Facilities
Pharmaceutical/Biotechnology/Medical Devices Companies
Educational & Research Institutes

Global ECOA, eSource & Clinical Trials Spending Analysis 2014-2018 and Forecast 2019-2029, by Region

North America
Latin America
Europe
Middle East and Africa (MEA)
East Asia
South Asia
Oceania

Need more information about Report Methodology? Click here- 

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4042

Spending on eCOA Set to Quadruple

The Fact.MR study opines that though the deployment of clinical trial solutions overshadowed the use of Electronic Clinical Outcome Assessment (eCOA), eSource, and EDA in 2018, the market is envisaged to witness a range of changes during the foreseeable period. The growing penetration of Bring Your Own Device (BYOD) trend in clinical trials is highly likely to pace up the use of eCOAs, such as ePROS, ClinROs, ObsROs, and PerfORs across a wide range of pharmaceutical companies and research facilities.

eCOAs is envisaged to hold ~45% of the overall spending share by the end of 2029, in line with the growing use of smartphones and tablets to seamlessly collect clinical data for analysis. Additionally, reduced cost and high scalability of eCOA are the primary determinants that continue to push its adoption during clinical trials, which is envisaged to contribute significantly to the growth of the eCOA, eSource & clinical trials market

Stakeholders Eyeing Opportunities through Collaborations

As the healthcare sector delves deeper into advanced technology, a large number of companies have formulated unique strategies to remain unaffected by the curve of change. Several pharmaceutical companies, research organizations, and CROs have placed their focus on collaborations, while they embrace digitization to create patient-centric experiences. For instance, Signant Health has launched a partner program to collaborate with Clinical Research Organizations (CROs) that are dedicated towards improving clinical trials using patient-centric technology.

Additionally, Iqvia has recently launched a novel eCOA cloud based technology platform to quantify the patient experience, while increasing efficiency and reducing timelines at the same time.

Growing Demand for Clinical Trials to Underpin Spending of Emerging Regions

As per the Fact.MR study, the increasing prevalence of various chronic infectious diseases has led to a dire unmet need for efficient clinical trials in developing countries. Moreover the rising medical expense in these regions, which can be attributed to the fact that private hospitals are the key healthcare providers herein, continue to fuel clinical trial participation in developing countries. This, coupled with the growing awareness about the cost and efficiency benefits of using eCOA, eSource & clinical trial solutions for conducting clinic trials, and comparatively lenient regulatory framework are likely to add to the lucrativeness of developing countries, such as China and India for market players.

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4042

Developed Regions Spearhead in Clinical Trials Deployment Rate

The rapidly advancing healthcare infrastructure, fast internet connectivity, and stringent regulatory product approval framework continue to make North America and Europe a hotbed of opportunities for stakeholders. With an increased number of companies getting cloud based (SaaS) deployment of clinical trial solutions in developed regions, owing to smooth internet connectivity, the market continues to accelerate at a steady pace. Cloud based deployment of digitized solutions accounted for 64% of the overall spending in Europe.

As per the study North America eCOA, eSource & clinical trials spending has been witnessing a steady growth over the years, with the US spending expected to account for ~90% revenue share in the regional eCOA, eSource & clinical trials spending in 2018. In view of the manifold cost and processing benefits of digitization in clinical trials, a larger number of pharmaceutical companies, contract research organizations, and education & research institutions have shifted their focus on paperless approaches. Growing adoption of clinical trial solutions, which contributed ~40% revenue share in North America eCOA, eSource, and clinical trials market, continue to create a window of opportunities of growth for market players.

For More Insights https://www.biospace.com/article/parenteral-drugs-market-growing-on-the-back-of-rising-demand-for-monoclonal-antibodies-fact-mr

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Over The Couter Vitamins and Dietary Supplements Is Set to Expand at 6.7% CAGR By 2022

According to the recently conducted study by Fact.MR, the global demand for OTC vitamins and dietary supplements is set to expand at 6.7% CAGR during the forecast period (2017-2022) to surpass a valuation of US$ 97,688 Mn.

OTC vitamin and dietary supplement products. Over-the-counter (OTC) vitamins and dietary supplements are sold directly to consumers without any medical prescription. In many countries, OTC vitamins and dietary supplement products are regulated to ensure that they are effective and safe when used.

Drug regulatory bodies allow manufacturers to formulate vitamin ingredients or combination of ingredients that are well tolerated and do not pose any risk of side effects or reactions.  In recent years, the healthcare sector has witness exponential growth, which has reflected positively on the global market for OTC vitamins and dietary supplements.

Click HERE To get a SAMPLE PDF (Including Full TOC, Table & Figures) at https://www.factmr.com/connectus/sample?flag=S&rep_id=61

Sales of such products have also increased in emerging countries such as China, India and Brazil primarily owing to the growing consumer awareness regarding the health benefits of such products. Convenience of direct purchase, cost-efficiency and growing trends of self-treatment are additional factors expected fuel the growth of the market. Moreover, manufacturers are also concentrating on developing advanced product formulations in order to improve their functionalities.

Need more information about Report Methodology? Click here-https://www.factmr.com/connectus/sample?flag=RM&rep_id=61

Market Segmentation

Global OTC Vitamins and Dietary Supplements Market Size and Forecast By Function

  • Immune Health
  • Digestive Health
  • Heart Health
  • Nutrition
  • Bone & Joint Health
  • General Well being
  • Weight Loss

Global OTC Vitamins and Dietary Supplements Market Size and Forecast By OTC Channel

  • Pharmacy
  • Drug Store
  • Modern Trade
  • Online Store
  • Other Retail

Global OTC Vitamins and Dietary Supplements Market Size and Forecast By Product Form

  • Liquid
  • Capsule
  • Tablet
  • Powder

Global OTC Vitamins and Dietary Supplements Market Size and Forecast By Region 

  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/61

Following insights from Fact.MR’s report on the global OTC vitamins and dietary supplements market will be crucial for market’s future growth

  • Among regions, North America is expected to remain one of the most lucrative market for OTC vitamins and dietary supplements between 2017 and 2022. The region currently commands for the highest value share of the global market as demand for various OTC drugs is on the rise particularly in the U.S. Asia Pacific excluding Japan (APEJ) is also projected to emerge as an attractive market for OTC vitamins and dietary supplements over 2022. In terms of revenue, the market in Europe is anticipated to command for over 31% share of the global market, by 2017-end.
  • On the basis of functions, OTC vitamins and dietary supplements are being used majorly for maintaining general well-being of the body. The general well-being segment accounts for a large percentage of the overall market revenue.
  • In 2017 and beyond, pharmacies will continue to be the top OCT channel for sales of OTC vitamin products including capsules and tablets. Over one-fourth revenue share of the global market is currently captured by the pharmacy OTC channel segment. Though, this OTC channel segment is expected to lose a small fraction of its revenue share over 2020, mainly due to emergence of new OCT channels such online retail and modern trade.
  • Sales of capsule based OTC vitamins and dietary supplements will continue to remain strong during the forecast period. By 2022-end, nearly US$ 32,891 Mn worth capsules are estimated to be sold across the globe.

For More Insights
https://www.biospace.com/article/implementation-of-novel-methods-for-active-pharmaceutical-ingredients-production-driving-contract-pharmaceutical-fermentation-services-market-fact-mr/

OTC vitamins and dietary supplements market include

  • Koninklijke DSM N.V.
  • Reckitt Benckiser LLC
  • Otsuka Holdings Co. Ltd.
  • CSPC Pharmaceutical Group Limited
  • Sanofi S.A.
  • Atrium Innovations Inc.
  • E. I. du Pont de Nemours and Co.
  • Bactolac Pharmaceutical Inc.
  • Dil Limited.
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Lonza Group Ltd.

About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Over US$ 390 Mn Worth of Vocal Biomarker are Envisaged to be Sold Across the Globe by 2027-end

According to a recent research analysis, sound vibrations, which were employed as therapeutic healing for mental health conditions, are now witnessing application into various disease diagnostics including psychiatric and cardiovascular ailments. Post-successful execution of clinical trials, HIPAA-compliant vocal biomarkers are set to serve as effective alternatives to currently available disease diagnostic systems such as CT scan, MRI and X-ray.

Prominent voice-based companies such as IBM Corporation, Cogito Corporation, Audio Profiling, Sonde Health, and Beyond Verbal are focusing on sampling data for providing accurate results. For example – Beyond Verbal has been taking immense research efforts on vocal biomarkers and has compiled over 2.5 Mn samples of voice in more than 40 different languages.

Click HERE To get a SAMPLE  (Including Full TOC, Table & Figures) at
https://www.factmr.com/connectus/sample?flag=S&rep_id=719

Prominent voice-based companies such as IBM Corporation, Cogito Corporation, Audio Profiling, Sonde Health, and Beyond Verbal are focusing on sampling data for providing accurate results. For example – Beyond Verbal has been taking immense research efforts on vocal biomarkers and has compiled over 2.5 Mn samples of voice in more than 40 different languages.

vocal biomarker market

Site Management by CROs Essential for Ensuring Vocal Biomarker Clinical Trails’ Success

Contract research organizations (CROs) are likely to spearhead the global vocal biomarker market, in terms of revenues as well as growth rate. Given the expanding range of voice-assistant, health-related applications, life sciences and healthcare organizations have commenced designing an array of scenarios to deploy voice assistant platforms in clinical trial settings. Integration of these platforms in the research for vocal biomarkers has the potential to address specific drawbacks in current clinical trial environment.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=719

Vocal Biomarker Market: Taxonomy and Segmentation Analysis

Region
  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA
Technique
  • Frequency
  • Amplitude
  • Error Rate
  • Vocal Rise Or Fall Time
  • Phonation Time
  • Voice Tremor
  • Pitch
  • Other Types
End User
  • Hospitals & Clinics
  • CROs
  • Academic and Research Center
  • Other End User
Indication
  • Psychiatric Disorders
  • Respiratory Disorders
  • Cardiovascular Disorders
  • Traumatic Brain Injury (TBI)
  • Neurological Disorders
  • Other Disorder

CROs are essential and play a key role in ensuring the clinical trials’ success through proper site management. Accurate level of site management & oversight prompts site to effectively recruit, train, and retain subjects, meanwhile ensuring overall management of subjects, protocol adherence, and regulatory compliance. CROs help in maintaining and improving the communication flow, thereby reducing protocol deviations & violations, and addressing data issues & queries. These benefits of CROs also effectively apply to quality and integrity of clinical trials apropos of vocal biomarkers.

Non-invasiveness of Vocal Biomarker in Psychiatric Disorder Diagnostics in Sync with Self-diagnosis’ Upward Trend

Sound vibrations have been employed as biomarkers for diagnosing psychiatric disorders such as depression and anxiety. Similar distinctive features, known as vocal biomarkers, have been recently discovered by scientists that might pose a massive influence on developing a diagnostic tool. Additionally, latest research analyses have greatly impacted application of vocal biomarkers in diagnosing psychiatric ailments ranging from stress to Parkinson’s disease.

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/719

Unlike other conventional and minimally invasive technologies such as ECG and MRI, which are impracticable for remote health monitoring on account of their high costs, vocal biomarkers serve as non-invasive diagnostic tools that provide great ease to patients with psychiatric disorders. Moreover, these significant user-friendly tools fall perfectly in line with the upward trend of self-diagnosis, which in turn has considerably fuelled their demand across the globe. Psychiatric disorders are likely to remain the leading indication in the global vocal biomarker market, with revenues estimated to rake in approximately US$ 130 Mn by 2027-end.

North America Vocal Biomarker Market: Driven by Government Agencies’ Tie-ups with Voice-Related Companies

Robust healthcare infrastructure, and presence of well-funded research organizations equipped with cutting-edge technologies in North America have made the region a lucrative breeding place for vocal biomarkers. Tie-ups of the U.S. government agencies with voice-based companies and analysis researchers is a primary demand determinant for vocal biomarkers in the region across areas such as geriatrics and war-induced trauma. For example, the U.S. Army entered into a collaboration with researchers from MIT for developing voice-based detection system to diagnose brain injuries.

For More Insights 
https://www.biospace.com/article/global-lung-cancer-diagnostics-market-set-to-expand-at-7-3-percent-cagr-through-2021-fact-mr

Fact.MR’s report foresees the global market for vocal biomarker to reflect a staggering expansion in the period of forecast, 2018 to 2027. Over US$ 390 Mn worth of vocal biomarkers are envisaged to be sold across the globe by 2027-end.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Gram-Negative Bacterial Sepsis to Soar with High Growth Observed In US : Report Fact.MR

Fact.MR’s revised sepsis diagnostics market study forecasts a healthy growth trajectory for FY 2021-22 and beyond, with the market expected to increase at a CAGR worth around 8% through 2031. Growth prospects were further underpinned amidst the coronavirus pandemic, attributed to the onset of pneumonia-induced sepsis and consequent fatalities.

According to the report, the market is expected to yield high short-term gains, generating over US$ 700 million in revenue by 2026. These are largely attributed to ongoing research & development initiatives amid a general upswing in ICU and hospital admission-induced sepsis amongst patients. Manufacturers are incorporating the latest automated technologies to ensure precision and timely diagnostics.

To remain ‘ahead’ of your competitors, request for a sample –

https://www.factmr.com/connectus/sample?flag=S&rep_id=391

Epidemiologically, an estimated 22 cases of childhood sepsis per 100,000 person-years and 2,202 cases of neonatal sepsis per 100,000 live births occur. This translates into 1.2 million cases of childhood sepsis annually. Most recent estimates attributed an adult prevalence rate of 19.4 million sepsis incidences, with over 5 million deaths. Hence, investments are underway to introduce highly sophisticated sepsis diagnostic approaches, which are expected to incline demand over the coming years.

“As the frequency of hospital admissions for various diseases increases, risk of developing sepsis during treatment is rising, prompting healthcare settings to incorporate sepsis diagnostics and detection systems, spurring heightened R&D to introduce new solutions,” comments a Fact.MR analyst.

Key Takeaways from Market Study

  • By product, kits & reagents to remain the most deployed sepsis diagnostic solutions
  • Automated sepsis diagnosis to acquire greater momentum, backed by key solutions launches by prominent manufacturers
  • By pathogen, gram positive bacterial sepsis diagnosis to acquire major momentum
  • By technology, microbiology testing is likely to tower over other approaches, with molecular diagnostics acquiring high momentum
  • Increasing regulatory approvals of key equipment by the Food & Drug Administration heightening U.S. sales prospects
  • The U.K. to experience high penetration amid rising government initiatives to rein in sepsis fatalities
  • Technological breakthroughs to widen growth prospects for the market in Germany
  • Dearth of institutional level preparedness to cope with sepsis patient deluge spurring adoption of advanced equipment across India

Have a Query? Connect to Research Analyst

https://www.factmr.com/connectus/sample?flag=AE&rep_id=391

global sepsis diagnostics market

Market Taxonomy

Product Type
  • Blood Culture Media
  • Instrument
  • Assays & Reagents
Method
  • Conventional Diagnostics
  • Automated Diagnostics
Pathogen
  • Gram-negative Bacterial Sepsis
  • Gram-positive Bacterial Sepsis
  • Fungal Sepsis
  • Other Pathogens
Technology
  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Other Technology

Full Access of this Report Is Available At

https://www.factmr.com/checkout/391

Competitive Landscape

The global sepsis diagnostics market is interspersed with the presence of a large number of diagnostic service providers, rendering it highly competitive in nature. Amongst all the expansion strategies deployed, offering technologically advanced solutions by virtue of conducting immense R&D remains the core objective.

  • For instance, Luminex Corporation, a pioneer in diagnostics testing, offers the VERIGENE® and VERIGENE® II Systems, specifically designed to target infections in the blood stream, respiratory tract and gastrointestinal tract. These systems use highly automated workflows, helping perform extraction, amplification, hybridization and detection, helping improve clinical outcomes by preventing the onset of sepsis.
  • Likewise, Abionic SA offers the abioSCOPE, a non-fluidic immunoassay technology, which was tested across 14 European hospitals on several hundred patients, with doctors confirming that in over 85% of the cases, sepsis detection was possible more than 24 hours prior as compared to standard care. The solution was approved for clinical trials across U.S. hospitals in 2020.
  • Abionic SA
  • Biomérieux SA
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.
  • Quidel Corporation
  • Becton
  • Dickinson and Company
  • Luminex Corporation
  • Abbott Laboratories Inc.
  • Qiagen NV

For More Insights

https://www.accesswire.com/641064/Personal-Flotation-Devices-Sales-to-Improve-with-Increasing-Demand-for-Water-Sports-Recreational-Activities-FactMR

Find More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the sepsis diagnostics market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (blood culture media, instruments, and assays & reagents), method (conventional diagnostics and automated diagnostics), pathogen (gram-negative bacterial species, gram-positive bacterial species, fungal species, and other pathogens), and technology (microbiology, molecular diagnostics, immunoassays and other technologies), across six major regions of the world (North America, Latin America, Europe, APEJ, Japan, and MEA).

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com